Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Tecfidera

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tecfidera was produced by Biogen Idec.

Novartis’ Gilenya fails in difficult-to-treat form of MS

Novartis’ Gilenya fails in difficult-to-treat form of MS hit market, including Sanofi's Aubagio (teriflunomide) and Biogen Idec's Tecfidera (dimethyl fumarate).

FDA adds rare brain infection link to Tecfidera labelling

FDA adds rare brain infection link to Tecfidera labelling As a result, information describing this case of PML is being added to the Tecfidera drug label.". ... Tecfidera has been predicted to become the leading treatment for MS, as its oral formulation is more patient-friendly than earlier injectable drugs

Cuts help Teva raise profits, despite flat sales

Cuts help Teva raise profits, despite flat sales After a 12% dip last quarter attributed to the impact of competition from oral MS therapies such as Biogen Idec's Tecfidera (dimethyl fumarate), Copaxone held up well with a 5%

Dive in: gaining leadership in a therapeutic area

Dive in: gaining leadership in a therapeutic area market withdrawal and reshaping MS with its highly successful Tecfidera launch 2013.

Final NICE backing for Biogen Idec's Tecfidera

Final NICE backing for Biogen Idec's Tecfidera In final guidance the National Institute for Health and Care Excellence (NICE) said Tecfidera (dimethyl fumarate) should be available as a treatment option for adults with the relapsing–remitting form of ... Now that NICE has issued final guidance NHS

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics